Latest papers

Hypolipidemic effect of arborium plus in experimentally induced hypercholestermic rabbits.

Absolute stereochemistry of pentacecilides, new inhibitors of lipid droplet formation in mouse macrophages, produced by Penicillium cecidicola FKI-3765-1.

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.

Synthesis of novel benzocoumarin derivatives as lipid lowering agents.

Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot study.

Involvement of angiotensin II in intestinal cholesterol absorption.

Establishment of a methodology for investigating protectants against ethanol-induced hepatotoxicity

Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents.

Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities.

Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome?

Hypolipidemic effect of the polysaccharide from Pholiota nameko

Efflux and uptake transporters as determinants of statin response.

Effects of combination lipid therapy in type 2 diabetes mellitus.

Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome.

[Pharmaceutical food science: search for anti-obese constituents from medicinal foods-anti-hyperlipidemic saponin constituents from the flowers of Bellis perennis].

Soluble polysaccharide composition and myo-inositol content help differentiate the antioxidative and hypolipidemic capacity of peeled apples.

Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Treatment of dyslipidaemia in childhood.

Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.